Evidence map›Paper›PMID 29391904›Full record

ArticleOncology letters2018

Hemacytotoxicity and natural killer lytic index: New parameters to evaluate natural killer cell immunity for clinical use in cancer.

Hyung Gun Maeng, Su Jin Lee, Yun A Lee, Hye Jeong Lee, Young Joo Kim, Jong Kyun Lee, Jae Cheol Kim, Joungbum Choi

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 85% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Hyung Gun MaengImmunology Laboratory, Holon Center, Seoul Song Do Colorectal Hospital, Seoul 04597, Republic of Korea.
Su Jin LeeImmunology Laboratory, Holon Center, Seoul Song Do Colorectal Hospital, Seoul 04597, Republic of Korea.
Yun A LeeImmunology Laboratory, Holon Center, Seoul Song Do Colorectal Hospital, Seoul 04597, Republic of Korea.
Hye Jeong LeeImmunology Laboratory, Holon Center, Seoul Song Do Colorectal Hospital, Seoul 04597, Republic of Korea.
Young Joo KimImmunology Laboratory, Holon Center, Seoul Song Do Colorectal Hospital, Seoul 04597, Republic of Korea.
Jong Kyun LeeImmunology Laboratory, Holon Center, Seoul Song Do Colorectal Hospital, Seoul 04597, Republic of Korea.
Jae Cheol KimImmunology Laboratory, Holon Center, Seoul Song Do Colorectal Hospital, Seoul 04597, Republic of Korea.
Joungbum ChoiImmunology Laboratory, Holon Center, Seoul Song Do Colorectal Hospital, Seoul 04597, Republic of Korea.
Songdo Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cytotoxicity assays with patient peripheral blood mononuclear cell (PBMC)-derived natural killer (NK) cells are useful in evaluating the innate immunity of patients with cancer. However, the size of the NK cell population in PBMC preparations may have significant effects on the assay outcome. Therefore, the present study examined the effect of NK cell frequency in a cytotoxicity system to investigate NK cell immunity in post-surgical colorectal cancer patients. For this, hemacytotoxicity was assessed using PBMC preparations, and lymphocyte subset populations were analyzed in samples obtained from 47 patients and 45 healthy volunteers. In addition, a new theoretical parameter, the 'NK lytic index', was termed to represent the per-cell cytotoxicity and compensate for the NK cell frequency effect during PBMC preparations. Notably, the patterns of hemacytotoxicity and NK lytic index did not coincide in follow-up studies with consecutive patients following surgical intervention. In addition, it was determined that NK cell NKG2D expression influences NK lytic index, but not hemacytotoxicity. Transforming growth factor (TGF)-β-bound lymphocytes influenced hemacytotoxicity and NK lytic index. These findings indicate that total cell activity (hemacytotoxicity) is not a sum of per-cell activities (NK lytic indexes), suggesting that clinicians should employ NK lytic index in addition to hemacytotoxicity in order to precisely determine how to enhance NK cell immunity in patients with cancer, either focusing on recovering the number of NK cells or boosting NK cell activity in single cell levels, or both.

Indexed as

cell-mediated immunityclinical laboratory techniquesclinical oncologycolorectal cancernatural killer cells

Identifiers

PMID29391904
PMCPMC5769403
OpenAlexW2767950162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.